2022
DOI: 10.1016/j.inat.2021.101463
|View full text |Cite
|
Sign up to set email alerts
|

Survey of practice preferences in deep brain stimulation surgery in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…Motor symptom asymmetry is a defining clinical feature of PD. Our routine clinical practice is to treat the most severely affected hemibody with unilateral DBS, followed by staged surgery on the opposite side of the brain (when, and if, needed) 24–27 . The same neurosurgeons (B.G., J.N.B.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Motor symptom asymmetry is a defining clinical feature of PD. Our routine clinical practice is to treat the most severely affected hemibody with unilateral DBS, followed by staged surgery on the opposite side of the brain (when, and if, needed) 24–27 . The same neurosurgeons (B.G., J.N.B.…”
Section: Methodsmentioning
confidence: 99%
“…Our routine clinical practice is to treat the most severely affected hemibody with unilateral DBS, followed by staged surgery on the opposite side of the brain (when, and if, needed). [24][25][26][27] The same neurosurgeons (B.G., J.N.B. )kjm implanted a 1-3-3-1 directional lead (Boston Scientific Vercise DBS system, Natick MA, USA, FDA IDE# G170063) at the STN target under local anesthesia with the patient fully awake.…”
Section: Surgical Procedures and Stimulation Parametersmentioning
confidence: 99%
“…Motor symptom asymmetry is a defining clinical feature of PD. Our routine clinical practice is to treat the most severely affected hemibody with unilateral DBS, followed by staged surgery on the opposite side of the brain (when, and if, needed) [24][25][26][27][28] . The same neurosurgeons (BG, JNB) implanted a 1-3-3-1 directional lead (Boston Scientific Vercise DBS system, Natick MA, USA, FDA IDE# G170063) at the STN target under local anesthesia with the patient fully awake.…”
Section: Surgical Procedures and Stimulation Parametersmentioning
confidence: 99%